Ieq Capital LLC decreased its holdings in Align Technology, Inc. (NASDAQ:ALGN – Free Report) by 1.0% in the second quarter, Holdings Channel reports. The firm owned 35,415 shares of the medical equipment provider’s stock after selling 357 shares during the period. Ieq Capital LLC’s holdings in Align Technology were worth $8,550,000 as of its most recent SEC filing.
Other hedge funds also recently added to or reduced their stakes in the company. Gryphon Financial Partners LLC boosted its holdings in Align Technology by 31.0% in the fourth quarter. Gryphon Financial Partners LLC now owns 1,396 shares of the medical equipment provider’s stock worth $383,000 after acquiring an additional 330 shares in the last quarter. Dimensional Fund Advisors LP raised its position in shares of Align Technology by 3.5% in the 4th quarter. Dimensional Fund Advisors LP now owns 213,667 shares of the medical equipment provider’s stock valued at $58,548,000 after purchasing an additional 7,266 shares during the last quarter. Janney Montgomery Scott LLC boosted its stake in Align Technology by 34.0% in the 4th quarter. Janney Montgomery Scott LLC now owns 12,546 shares of the medical equipment provider’s stock worth $3,438,000 after purchasing an additional 3,185 shares in the last quarter. Coldstream Capital Management Inc. grew its position in Align Technology by 19.2% during the 4th quarter. Coldstream Capital Management Inc. now owns 1,941 shares of the medical equipment provider’s stock worth $532,000 after purchasing an additional 313 shares during the last quarter. Finally, D.A. Davidson & CO. increased its stake in Align Technology by 4.5% during the 4th quarter. D.A. Davidson & CO. now owns 4,644 shares of the medical equipment provider’s stock valued at $1,272,000 after purchasing an additional 200 shares in the last quarter. 88.43% of the stock is owned by institutional investors and hedge funds.
Align Technology Trading Up 1.6 %
Align Technology stock opened at $257.17 on Friday. The firm has a market cap of $19.36 billion, a PE ratio of 42.37, a P/E/G ratio of 5.13 and a beta of 1.64. Align Technology, Inc. has a 12 month low of $176.34 and a 12 month high of $335.40. The stock’s 50 day simple moving average is $232.30 and its two-hundred day simple moving average is $265.24.
Wall Street Analysts Forecast Growth
A number of brokerages have recently weighed in on ALGN. Robert W. Baird dropped their price objective on shares of Align Technology from $370.00 to $325.00 and set an “outperform” rating on the stock in a report on Monday, July 22nd. OTR Global reiterated a “mixed” rating on shares of Align Technology in a research note on Tuesday, June 4th. Morgan Stanley reduced their price objective on Align Technology from $328.00 to $310.00 and set an “overweight” rating for the company in a research note on Thursday, July 25th. StockNews.com upgraded Align Technology from a “hold” rating to a “buy” rating in a research report on Thursday. Finally, Evercore ISI reduced their price target on shares of Align Technology from $370.00 to $300.00 and set an “outperform” rating for the company in a research report on Monday, June 10th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $306.88.
View Our Latest Stock Analysis on Align Technology
Insider Activity
In other Align Technology news, Director C Raymond Larkin, Jr. purchased 6,500 shares of Align Technology stock in a transaction that occurred on Thursday, August 15th. The stock was bought at an average price of $235.33 per share, with a total value of $1,529,645.00. Following the acquisition, the director now owns 28,247 shares of the company’s stock, valued at approximately $6,647,366.51. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.62% of the company’s stock.
Align Technology Profile
Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.
Featured Articles
- Five stocks we like better than Align Technology
- The How And Why of Investing in Oil Stocks
- Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
- What Are Dividend Contenders? Investing in Dividend Contenders
- How the Fed’s Rate Cut Could Supercharge These 3 ETFs
- What is a Stock Market Index and How Do You Use Them?
- Microsoft Stock: 3 Reasons It’s Ready to Crush Q4
Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN – Free Report).
Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.